TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/27/21 16:43 | 7/23/21 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hardy Reginald L | CO | DO | CB | P.m | 134 | 0.6683 | 0 | 200 | 34 | 780 | D | ||||||||||||||
9/2/20 16:21 | 8/31/20 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hardy Reginald L | CO | DO | CB | M.d | 0 | 0.00 | 0 | 1 | 0 | 523 | D | ||||||||||||||
8/4/20 16:57 | 7/31/20 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hardy Reginald L | CO | DO | CB | M.d | 0 | 0.00 | 0 | 1 | 0 | 529 | D | ||||||||||||||
7/2/20 14:01 | 6/30/20 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hardy Reginald L | CO | DO | CB | M.d | 0 | 0.00 | 0 | 1 | 0 | 529 | D | ||||||||||||||
6/5/20 17:24 | 2/14/20 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hardy Reginald L | CO | DO | CB | M.dm | 0 | 0.00 | 0 | 8 | 2 | 528 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |